$0.62 - VYNE | VYNE Therapeutics Inc. Common Stock

VYNE Therapeutics Inc. Common Stock (VYNE)

VYNE Therapeutics Inc. Common Stock

XNAS:VYNE

0.62

53.09%

Ask

$0.62 - 500.00

Bid

$0.62 - 100.00

Low

$0.56

High

$0.75

Open

$0.72

Prev Close

$0.4

52W High

4.3

52W Low

0.28

Volume

234545121

Avg Vol (3m)

1040014

Float

31146350.77

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 01/25/2018

Primary Exchange: XNAS

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Phone: 800-775-7936

Address: 685 Route 202/206 N., Suite 301

City: Bridgewater

State: NJ

Postal Code: 08807

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-0.510000

P/B (TTM)

0.356464

Round Lot

100

Composit FIGI

BBG00H5W8GM8

Share Class FIGI

BBG00H5W8GN7

Share Class Shares Outstanding

25.47M

Weighted Shares Outstanding

25.47M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion